Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1D (migalastat)1件: Migalastat1件: Migalastat 💬--1件: 19 💬
2D Mannose1件: Mannose---1件: 13 💬
3D-a-tocopheryl PEG 1000 succinate----1件: 299 💬
4D-aspartate----1件: 13 💬
5D-BIOTIN1件: Biotin1件: Biotin 💬--3件: 10, 13, 20 💬
6D-BIOTINA1件: Biotin1件: Biotin 💬--1件: 13 💬
7D-CURA----1件: 96 💬
8D-Cure----1件: 228 💬
9D-Galactose1件: Galactose1件: Galactose 💬--1件: 222 💬
10D-glucitol1件: Sorbitol1件: Sorbitol solution 💬--2件: 28, 299 💬
11D-glucitol, 1-deoxy-1-(methylamino)-, 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1)1件: Sorbitol1件: Sorbitol solution 💬--1件: 28 💬
12D-glucitol, 1-deoxy-1-(methylamino)-,2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1)1件: Sorbitol1件: Sorbitol solution 💬--1件: 28 💬
13D-glucose2件: D-glucose,
Dextrose, unspecified form
1件: Glucose 💬--3件: 49, 86, 88 💬
14D-IVA----1件: 299 💬
15D-methylphenidate1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬
7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 84 💬
16D-penicillamine1件: Penicillamine1件: Penicillamine 💬--1件: 171 💬
17D-penicillamine 150mg1件: Penicillamine1件: Penicillamine 💬--1件: 171 💬
18D-penicillamine 250 mg1件: Penicillamine1件: Penicillamine 💬--1件: 171 💬
19D-Proline2件: D-Proline,
Proline
1件: Proline 💬--1件: 97 💬
20D-Serine2件: D-Serine,
Serine
1件: Serine 💬--1件: 6 💬
21D-serine (~2g/day)2件: D-Serine,
Serine
1件: Serine 💬--1件: 6 💬
22D-SORBITOL1件: Sorbitol1件: Sorbitol solution 💬--1件: 10 💬
23D.3.2 Product code where applicable13:----1件: 193 💬
24D.3.6.2 - dose massima specificare: giornaliera----1件: 86 💬
25D.3.6.2.1 - valore: 45 / 0.45 mg/ml----1件: 97 💬
26D.3.6.2.1 - valore: 5 o 10 mg/kg----1件: 97 💬
27D2E7----1件: 46 💬
28D3 VitaCaps®----2件: 96, 97 💬
29D569 Tab.----1件: 46 💬
30D6-25-hydroxyvitamin D31件: Calcifediol1件: Calcifediol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299 💬
31D9421-C----1件: 96 💬
32D9421-C capsule 3 mg----1件: 96 💬
33D9421-C, 15mg----1件: 96 💬
34D9421-C, 9mg----1件: 96 💬
35DA-9701----1件: 6 💬
36DA-9805 45mg----1件: 6 💬
37DA-9805 90mg----1件: 6 💬
38Dabigatran1件: Dabigatran1件: Dabigatran 💬1件: F2 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬5件: 51, 75, 85, 91, 124 💬
39Dabigatran etexilate2件: Dabigatran,
Dabigatran etexilate
2件: Dabigatran etexilate ,
Dabigatran 💬
1件: F2 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬2件: 51, 75 💬
40Dabrafenib1件: Dabrafenib1件: Dabrafenib 💬1件: BRAF 💬44件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Bladder cancer, Breast cancer, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanoma, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Renal cell carcinoma, Serotonergic synapse, Thyroid cancer, Vascular smooth muscle contraction, cAMP signaling pathway, mTOR signaling pathway 💬1件: 34 💬
41Dabu ying pills----1件: 76 💬
42DAC----1件: 13 💬
43DAC HYP----1件: 13 💬
44DAC-HYP----1件: 13 💬
45Dacepton 5 mg/ml----1件: 6 💬
46Dacepton 5 mg/ml infuusioneste, liuos----1件: 6 💬
47DACLIZUMAB1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬8件: 13, 56, 60, 65, 97, 107, 283, 284 💬
48Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
49Daclizumab High Yield Process1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
50DACLIZUMAB HYP1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
51Daclizumab HYP (DAC HYP1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
52Daclizumab HYP (DAC HYP)1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
53Daclizumab wih Greek suffix1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
54Daclizumab with Greek suufix1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
55DACORTIN----1件: 97 💬
56Dacortin ®----1件: 46 💬
57Dacortín 2,5mg----1件: 222 💬
58Dacortín 30mg----1件: 222 💬
59Dacortín 5mg----1件: 222 💬
60Daily hGH----1件: 78 💬
61Daily ingestion of Lactobacillus plantarum PS1281件: Lactobacillus plantarum---1件: 6 💬
62Daily rhGH1件: Somatotropin---1件: 78 💬
63Dalacin C----1件: 46 💬
64Dalacin C phosphate2件: Clindamycin,
Phosphate ion
1件: Clindamycin 💬--1件: 46 💬
65Dalfampridine1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬
4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 4, 13 💬
66Dalfampridine ER1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬
4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
67Dalfampridine ER, 10 Mg Oral Tablet, Extended Release1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬
4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
68Dalfampridine-ER 10mg1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬
4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
69Dalfampridine-ER 5mg1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬
4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
70Dalteparin1件: Dalteparin---1件: 222 💬
71Danazol1件: Danazol1件: Danazol 💬3件: AR,
ESR1,
PGR 💬
12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬5件: 60, 63, 64, 65, 285 💬
72DAND (14-Deoxyandrographolide)----1件: 97 💬
73DANICOPAN1件: Danicopan1件: Danicopan 💬1件: CFD 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬1件: 62 💬
74Danicopan (ALXN2040)1件: Danicopan1件: Danicopan 💬1件: CFD 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬1件: 62 💬
75Dantrolene1件: Dantrolene1件: Dantrolene 💬--2件: 13, 233 💬
76Dantrolene sodium1件: Dantrolene1件: Dantrolene 💬--1件: 233 💬
77Danzhu Fuyuan Granule----1件: 222 💬
78Dapagliflozin1件: Dapagliflozin1件: Dapagliflozin 💬1件: SLC5A2 💬-7件: 19, 49, 66, 67, 86, 88, 222 💬
79Dapagliflozin 10 MG [Farxiga]1件: Dapagliflozin1件: Dapagliflozin 💬1件: SLC5A2 💬-2件: 86, 88 💬
80Dapagliflozin 10mg Tab1件: Dapagliflozin1件: Dapagliflozin 💬1件: SLC5A2 💬-1件: 19 💬
81DAPIROLIZUMAB PEGOL1件: Dapirolizumab pegol---2件: 13, 49 💬
82Dapirolizumab pegol (DZP)1件: Dapirolizumab pegol---1件: 49 💬
83Dapsone1件: Dapsone1件: Dapsone 💬--5件: 35, 42, 60, 84, 162 💬
84Daraprim1件: Pyrimethamine1件: Pyrimethamine 💬--2件: 2, 4 💬
85Daratumumab1件: Daratumumab1件: Daratumumab 💬1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬5件: 13, 28, 48, 49, 63 💬
86Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20)3件: Daratumumab,
Hyaluronidase,
Hyaluronidase (human recombinant)
4件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase ,
Daratumumab 💬
1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬1件: 28 💬
87Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20)1件: Daratumumab1件: Daratumumab 💬1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬1件: 28 💬
88Daratumumab Injection1件: Daratumumab1件: Daratumumab 💬1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬3件: 28, 49, 63 💬
89Darifenacin1件: Darifenacin1件: Darifenacin 💬1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬2件: 6, 13 💬
90Darifenacin (BAY79-4998)1件: Darifenacin1件: Darifenacin 💬1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 13 💬
91Dark chocolate (85% cocoa)1件: Cocoa---1件: 6 💬
92Darunavir1件: Darunavir1件: Darunavir 💬--1件: 2 💬
93DARVADSTROCEL1件: Darvadstrocel1件: Darvadstrocel 💬--1件: 96 💬
94Darvocet----1件: 70 💬
95Darzalex1件: Daratumumab1件: Daratumumab 💬1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬3件: 28, 49, 63 💬
96DAS-001----1件: 11 💬
97Dasatinib1件: Dasatinib2件: Dasatinib ,
Dasatinib 💬
8件: ABL1,
EPHA2,
FYN,
KIT,
LCK,
PDGFRB,
SRC,
YES1 💬
77件: Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬2件: 51, 85 💬
98Dasatinib + Quercetin2件: Dasatinib,
Quercetin
2件: Dasatinib ,
Dasatinib 💬
8件: ABL1,
EPHA2,
FYN,
KIT,
LCK,
PDGFRB,
SRC,
YES1 💬
77件: Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬1件: 85 💬
99Data collection----1件: 65 💬
100Data report----1件: 162 💬
101DaTSCAN1件: Ioflupane I-123---3件: 2, 5, 6 💬
102DaTSCAN 74 MBq/ml solution for injection1件: Ioflupane I-123---1件: 6 💬
103Daunorubicin1件: Daunorubicin1件: Daunorubicin 💬2件: TOP2A,
TOP2B 💬
1件: Platinum drug resistance 💬1件: 65 💬
104Davunetide1件: Davunetide1件: Davunetide 💬--3件: 5, 7, 127 💬
105Davunetide (AL-108, NAP)1件: Davunetide1件: Davunetide 💬--3件: 5, 7, 127 💬
106Daxdilimab1件: Daxdilimab1件: Daxdilimab 💬1件: LILRA4 💬2件: B cell receptor signaling pathway, Osteoclast differentiation 💬2件: 49, 50 💬
107DAZARLEX----1件: 28 💬
108Dazucorilant 150 mg----1件: 2 💬
109Dazucorilant 300 mg----1件: 2 💬
110DB adalimumab 40 mg eow1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
111DB adalimumab 40 mg ew1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
112DB289----1件: 65 💬
113DC-TAB----1件: 13 💬
114DC158AM----1件: 6 💬
115DCCR----1件: 193 💬
116DCI----2件: 6, 299 💬
117DCI 1020----1件: 299 💬
118DCR-1171X----1件: 234 💬
119DCR-L1360----1件: 234 💬
120DCR-PH1----1件: 234 💬
121DCR-PHXC----1件: 234 💬
122DDAND (14-deoxy-11,12-didehydroandrographolide)----1件: 97 💬
123DDAVP1件: Desmopressin1件: Desmopressin 💬2件: AVPR2,
F8 💬
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬2件: 75, 288 💬
124DDAVP (Desmopressin)1件: Desmopressin1件: Desmopressin 💬2件: AVPR2,
F8 💬
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 288 💬
125DDS----1件: 90 💬
126Deanol1件: Deanol1件: Deanol 💬--1件: 6 💬
127Deanol pyroglutamate1件: Deanol1件: Deanol 💬--1件: 6 💬
128Deaxamethasone----1件: 28 💬
129DEBRUMYL----1件: 6 💬
130Decadron1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
131Decadron Phosphate, Injectable1件: Phosphate ion---1件: 70 💬
132Decitabine1件: Decitabine1件: Decitabine 💬3件: DNMT1,
DNMT3A,
DNMT3B 💬
3件: Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer 💬2件: 60, 63 💬
133Decolonization----1件: 299 💬
134Decortin----2件: 46, 113 💬
135DECORTIN (PREDNISONA) 5 MG COMPRIMIDOS1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
136Decortin 20 mg----1件: 96 💬
137Decortin 5 mg----1件: 96 💬
138Decortin 5mg tablets----1件: 46 💬
139Decortin H----3件: 66, 97, 145 💬
140Decortin H 1 mg----1件: 97 💬
141Decortin H 10mg----1件: 97 💬
142Decortin H 20mg----1件: 97 💬
143Decortin H 50 mg----1件: 97 💬
144Decortin H 5mg----1件: 97 💬
145Decortin®----1件: 46 💬
146Decrease Tocilizumab, Abatacept2件: Abatacept,
Tocilizumab
2件: Tocilizumab ,
Abatacept 💬
3件: CD80,
CD86,
IL6R 💬
25件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46 💬
147Dectancyl----1件: 81 💬
148Defanyl 50 and 100 mg----1件: 46 💬
149Deferasirox1件: Deferasirox1件: Deferasirox 💬--3件: 254, 284, 286 💬
150DEFERIPRONE1件: Deferiprone1件: Deferiprone 💬--6件: 2, 6, 18, 120, 122, 233 💬
151Deferiprone (Ferriprox)1件: Deferiprone1件: Deferiprone 💬--1件: 6 💬
152Deferiprone 20mg1件: Deferiprone1件: Deferiprone 💬--1件: 6 💬
153Deferiprone 30mg1件: Deferiprone1件: Deferiprone 💬--1件: 6 💬
154Deferiprone 600 mg delayed release tablet1件: Deferiprone1件: Deferiprone 💬--1件: 6 💬
155Deferiprone 80 mg/mL oral solution1件: Deferiprone1件: Deferiprone 💬--1件: 120 💬
156Deferiprone 80 mg/mL oral solution (Ferriprox)1件: Deferiprone1件: Deferiprone 💬--1件: 120 💬
157Deferiprone DR1件: Deferiprone1件: Deferiprone 💬--2件: 2, 6 💬
158Deferiprone oral solution1件: Deferiprone1件: Deferiprone 💬--1件: 120 💬
159Deferiprone treated1件: Deferiprone1件: Deferiprone 💬--1件: 120 💬
160Deferitazole1件: Deferitazole1件: Deferitazole 💬--1件: 284 💬
161Deferoxamine1件: Deferoxamine1件: Deferoxamine 💬--2件: 284, 286 💬
162DEFEROXAMINE MESILATE1件: Deferoxamine1件: Deferoxamine 💬--1件: 286 💬
163DEFLAN*10CPR 6MG----1件: 113 💬
164Deflazacort1件: Deflazacort1件: Deflazacort 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 30, 113 💬
165Deflazacort 6 mg Tablets1件: Deflazacort1件: Deflazacort 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
166Dehydrated Alcohol (Absolute Alcohol) BP for Injection1件: Ethanol1件: Ethanol 💬--1件: 279 💬
167Dehydrated human amnion/chorion membrane----1件: 269 💬
168Dehydroepiandrosterone1件: Prasterone1件: Prasterone 💬3件: AR,
ESR1,
ESR2 💬
12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬5件: 49, 53, 83, 96, 113 💬
169Dehydroepiandrosterone (DHEA)1件: Prasterone1件: Prasterone 💬3件: AR,
ESR1,
ESR2 💬
12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 49 💬
170Dehydroepiandrosterone 100 and 400 mg1件: Prasterone1件: Prasterone 💬3件: AR,
ESR1,
ESR2 💬
12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 113 💬
171Dehydroepiandrosterone [DHEA]1件: Prasterone1件: Prasterone 💬3件: AR,
ESR1,
ESR2 💬
12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 96 💬
172Dekavil----2件: 46, 97 💬
173Dekristol----2件: 13, 97 💬
174Dekristol 20.000 ie----1件: 96 💬
175Dekristol 20000 IE----1件: 13 💬
176Dekristol® 400-Tabletten----1件: 13 💬
177Dekristol®-Tablette 1 (400 IE)----1件: 13 💬
178Deksmedetomidiini----1件: 70 💬
179Delayed and extended release mesalazine1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
180Delayed Release 6 mercaptopurine1件: Mercaptopurine2件: Mercaptopurine ,
Mercaptopurine 💬
1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 96 💬
181Delayed Release 6MP or Calcitriol vs. Purinethol1件: Calcitriol1件: Calcitriol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
182Deligoparin----1件: 97 💬
183Delix----1件: 218 💬
184Delmitide acetate1件: Acetate---1件: 97 💬
185Delta-9-tetrahydrocannabinol1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬3件: 8, 13, 36 💬
186Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)2件: Cannabidiol,
Dronabinol
2件: Dronabinol ,
Cannabidiol 💬
2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 8 💬
187DELTACORTENE----2件: 43, 97 💬
188Deltacortene 10 cpr 25mg----1件: 97 💬
189Deltacortene 20 cpr 5mg----1件: 97 💬
190DELTACORTENE FORTE*10CPR 25MG----2件: 46, 97 💬
191DELTACORTENE*10CPR 25MG----1件: 84 💬
192DELTACORTENE*20CPR 5MG----3件: 49, 97, 113 💬
193Deltacortril----1件: 46 💬
194Deltacortril Enteric----1件: 46 💬
195DEMESTRIL SEPTEM----1件: 13 💬
196Demineralized Bone Matrix----1件: 70 💬
197Denosumab1件: Denosumab1件: Denosumab 💬1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬8件: 46, 50, 70, 93, 95, 96, 274, 299 💬
198Denosumab - - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand1件: Denosumab1件: Denosumab 💬1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 274 💬
199Denosumab - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand1件: Denosumab1件: Denosumab 💬1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 274 💬
200Denufosol1件: Denufosol---1件: 299 💬
201Denufosol tetrasodium (INS37217)1件: Denufosol---1件: 299 💬
202Denufosol Tetrasodium (INS37217) Inhalation Solution1件: Denufosol---1件: 299 💬
203Denufosol tetrasodium Inhalation Solution1件: Denufosol---1件: 299 💬
204Denusomab----1件: 274 💬
205Deoxynojirimycin1件: Duvoglustat1件: Duvoglustat 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
206Depakine----2件: 102, 233 💬
207DEPAKINE CHRONO 500 mg----1件: 233 💬
208DEPAKINE CHRONO® 500 mg----1件: 233 💬
209DEPALGOS*20+325MG 28CPR RP----1件: 46 💬
210DEPELESTAT----1件: 299 💬
211Depemedrone----1件: 46 💬
212Depemokimab----2件: 44, 45 💬
213Depleted Stem Cell Transplant----1件: 285 💬
214Depletion in CD45RA graft donor----1件: 65 💬
215Depletion of CD3/CD19 in an autologous stem cell transplant----2件: 49, 51 💬
216Depo Medrol----1件: 46 💬
217Depo-Medrol 40Mg/Ml Suspension for Injection----1件: 70 💬
218Depo-Medrone----1件: 46 💬
219DepoMedrol----1件: 70 💬
220Depot leuprolide acetate 3.75 mg2件: Acetate,
Leuprolide
---1件: 51 💬
221Depot tetracosactide1件: Tetracosactide1件: Cosyntropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 83 💬
222Deprakine----1件: 256 💬
223Dermoval----2件: 35, 162 💬
224Dersalazina sodica----1件: 97 💬
225Dersalazine1件: Dersalazine---1件: 97 💬
226Dersalazine sodium1件: Dersalazine---1件: 97 💬
227Dersimelagon----2件: 51, 254 💬
228DESAMETASONE----1件: 28 💬
229Descartes-08----1件: 11 💬
230Desert Harvest Aloe Vera Capsules1件: Aloe vera leaf---1件: 226 💬
231Desferal1件: Deferoxamine1件: Deferoxamine 💬--2件: 284, 286 💬
232Desferasirox----1件: 60 💬
233Desferrioxamine1件: Deferoxamine1件: Deferoxamine 💬--2件: 51, 53 💬
234Desflurane1件: Desflurane1件: Desflurane 💬--2件: 22, 296 💬
235Desflurane anesthetics1件: Desflurane1件: Desflurane 💬--1件: 296 💬
236Desipramine1件: Desipramine1件: Desipramine 💬2件: SLC6A2,
SLC6A4 💬
2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 120, 156 💬
237Desloratadine1件: Desloratadine1件: Desloratadine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
238Desloratadine given orally1件: Desloratadine1件: Desloratadine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
239Desmopressin1件: Desmopressin1件: Desmopressin 💬2件: AVPR2,
F8 💬
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬5件: 6, 64, 72, 225, 288 💬
240Desmopressin Acetat1件: Desmopressin1件: Desmopressin 💬2件: AVPR2,
F8 💬
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 6 💬
241Desmopressin acetate2件: Acetate,
Desmopressin
1件: Desmopressin 💬2件: AVPR2,
F8 💬
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬2件: 64, 288 💬
242DESMOPRESSIN ACETATE TRIHYDRATE2件: Acetate,
Desmopressin
1件: Desmopressin 💬2件: AVPR2,
F8 💬
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 225 💬
243Desmopressin intranasal1件: Desmopressin1件: Desmopressin 💬2件: AVPR2,
F8 💬
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
244Desmopressin Oral Melt1件: Desmopressin1件: Desmopressin 💬2件: AVPR2,
F8 💬
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
245Desmopressine1件: Desmopressin1件: Desmopressin 💬2件: AVPR2,
F8 💬
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬2件: 225, 288 💬
246Desmopressine nasal spray 10 mg/ml, flacon 60 doses1件: Desmopressin1件: Desmopressin 💬2件: AVPR2,
F8 💬
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 225 💬
247Desmotabs----1件: 6 💬
248Desmotabs® 0,2 mg Tabletten----1件: 6 💬
249Desmotabs® 0,2mg Tabletten----1件: 6 💬
250Desogestrel1件: Desogestrel1件: Desogestrel 💬2件: ESR1,
PGR 💬
11件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 230 💬
251Desoxyribonuclease1件: Desoxyribonuclease---1件: 299 💬
252Detemir1件: Insulin detemir1件: Insulin detemir 💬1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299 💬
253Determination of drug effects through amantadine cessation1件: Amantadine1件: Amantadine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
254Detoxifying agents for antineoplastic treatment----2件: 299, 337 💬
255Deucravacitinib1件: Deucravacitinib1件: Deucravacitinib 💬1件: TYK2 💬16件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis 💬3件: 49, 96, 97 💬
256Deupirfenidone----1件: 85 💬
257Deuterated Ivacaftor1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
258Deutetrabenazine1件: Deutetrabenazine1件: Deutetrabenazine 💬1件: SLC18A2 💬7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 8 💬
259Deutetrabenazine Oral Tablet [Austedo]1件: Deutetrabenazine1件: Deutetrabenazine 💬1件: SLC18A2 💬7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 8 💬
260DEUTIVACAFTOR1件: Deutivacaftor1件: Deutivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
261DEX284----1件: 85 💬
262Dexametasona1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
263Dexametasone----1件: 28 💬
264Dexametasone Fosfato Sodico----1件: 65 💬
265Dexamethason----4件: 13, 28, 46, 331 💬
266Dexamethasone1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
267Dexamethasone (1 cycle)1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
268Dexamethasone (4 cycles)1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
269Dexamethasone (50mg 1dd6, 3 consecutive days/month)1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 35 💬
270Dexamethasone (or equivalent)1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 257 💬
271Dexamethasone 0,1 mg Tablets1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
272Dexamethasone 0,5mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
273Dexamethasone 0.5mg Tablet1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
274Dexamethasone 0.5mg/5ml solution1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 35, 162 💬
275Dexamethasone 0.5mg/5ml solution in Mucolox™1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 35, 162 💬
276Dexamethasone 1,5 mg Tablets1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
277Dexamethasone 21-dihydrogen phosphate3件: Dexamethasone,
Hydrogen,
Phosphate ion
1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
278Dexamethasone 21-phosphate2件: Dexamethasone,
Phosphate ion
1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
279Dexamethasone 2mg Tablets1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
280Dexamethasone 4 mg JENAPHARM1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
281Dexamethasone Abcur1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
282Dexamethasone and Rituximab2件: Dexamethasone,
Rituximab
2件: Dexamethasone ,
Rituximab 💬
2件: MS4A1,
NR3C1 💬
2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 63 💬
283Dexamethasone given orally1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
284Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland).1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 235 💬
285Dexamethasone Oral, 10 mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
286Dexamethasone Oral, 20 mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
287Dexamethasone Parotid Irrigation1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 53 💬
288DEXAMETHASONE SODIUM PHOSPHATE2件: Dexamethasone,
Phosphate ion
1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 65, 70, 96 💬
289Dexamethasone sodium phosphate (soluzione 25mg/ml)2件: Dexamethasone,
Phosphate ion
1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
290Dexamethasone sodium phosphate 250 mg/ 10 ml2件: Dexamethasone,
Phosphate ion
1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
291Dexamethasone sodium phosphate 250 mg/10 ml solution2件: Dexamethasone,
Phosphate ion
1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 299 💬
292DEXAMETHASONE SODIUM PHOSPHATE PH. EUR.2件: Dexamethasone,
Phosphate ion
1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
293DEXAMETHASONE SODIUM SULFATE3件: Dexamethasone,
Sodium sulfate,
Sulfate ion
2件: Dexamethasone ,
Sodium sulfate 💬
1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
294Dexamethasone soduim phosphate2件: Dexamethasone,
Phosphate ion
1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
295Dexamethasone, 40 mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
296Dexamethasone, procarbazine2件: Dexamethasone,
Procarbazine
2件: Dexamethasone ,
Procarbazine 💬
1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
297Dexaton----1件: 28 💬
298Dexchlorpheniramine1件: Dexchlorpheniramine1件: Dexchlorpheniramine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬2件: 13, 49 💬
299Dexdor1件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬4件: 2, 4, 6, 70 💬
300Dexlansoprazole1件: Dexlansoprazole1件: Dexlansoprazole 💬2件: ATP4A,
ATP4B 💬
4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 98 💬
301DEXMEDETOMIDINA1件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
302DEXMEDETOMIDINE1件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬14件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
303Dexmedetomidine 11件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
304Dexmedetomidine 21件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
305Dexmedetomidine 31件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
306Dexmedetomidine group1件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
307Dexmedetomidine Hcl 100 Mcg/mL Inj1件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
308DEXMEDETOMIDINE HYDROCHLORIDE1件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
309Dexmedetomidine Hydrochloride Infusion1件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
310Dexmedetomidine with ropivacaine2件: Dexmedetomidine,
Ropivacaine
2件: Dexmedetomidine ,
Ropivacaine 💬
8件: ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
5件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬1件: 70 💬
311Dexpramipexole1件: Dexpramipexole1件: Dexpramipexole 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
312Dexpramipexole (dose 1)1件: Dexpramipexole1件: Dexpramipexole 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
313Dexpramipexole (dose 2)1件: Dexpramipexole1件: Dexpramipexole 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
314Dexpramipexole Dichydrochloride1件: Dexpramipexole1件: Dexpramipexole 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
315Dexpramipexole Dihydrochloride1件: Dexpramipexole1件: Dexpramipexole 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
316Dexrazoxane1件: Dexrazoxane1件: Dexrazoxane 💬2件: TOP2A,
TOP2B 💬
1件: Platinum drug resistance 💬1件: 13 💬
317Dexrazoxane (DRZ) plus Mitoxantrone (MX)2件: Dexrazoxane,
Mitoxantrone
2件: Dexrazoxane ,
Mitoxantrone 💬
2件: TOP2A,
TOP2B 💬
1件: Platinum drug resistance 💬1件: 13 💬
318Dextran1件: Dextran1件: Dextran 1 💬--4件: 2, 62, 96, 97 💬
319DEXTRAN 1 FOR INJECTION1件: Dextran1件: Dextran 1 💬--1件: 97 💬
320Dextran Sodium Sulfur Salt 5, Mw 5 kDa. a type of Low Molecular Weight Dextran Sulfate (LMW-DS)2件: Dextran,
Sulfate ion
1件: Dextran 1 💬--1件: 2 💬
321DEXTRAN SULFATE SODIUM2件: Dextran,
Sulfate ion
1件: Dextran 1 💬--1件: 2 💬
322Dextromethorphan1件: Dextromethorphan1件: Dextromethorphan 💬6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬
20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬
323Dextromethorphan and Caffeine2件: Caffeine,
Dextromethorphan
3件: Caffeine ,
Caffeine hydrate ,
Dextromethorphan 💬
17件: ADORA1,
ADORA2A,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A,
SIGMAR1 💬
37件: Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Huntington disease, Insulin signaling pathway, Long-term potentiation, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 78 💬
324Dextromethorphan HBr and quinidine sulfate3件: Dextromethorphan,
Quinidine,
Sulfate ion
2件: Dextromethorphan ,
Quinidine 💬
11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬
22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 2 💬
325DEXTROMETHORPHAN HYDROBROMIDE1件: Dextromethorphan1件: Dextromethorphan 💬6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬
20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 13, 46 💬
326Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg3件: Dextromethorphan,
Quinidine,
Sulfate ion
2件: Dextromethorphan ,
Quinidine 💬
11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬
22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬2件: 2, 13 💬
327Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg3件: Dextromethorphan,
Quinidine,
Sulfate ion
2件: Dextromethorphan ,
Quinidine 💬
11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬
22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬2件: 2, 13 💬
328Dextromethorphan/Quinidine2件: Dextromethorphan,
Quinidine
2件: Dextromethorphan ,
Quinidine 💬
11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬
22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
329Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg)2件: Dextromethorphan,
Quinidine
2件: Dextromethorphan ,
Quinidine 💬
11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬
22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 8 💬
330Dextrometorfano1件: Dextromethorphan1件: Dextromethorphan 💬6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬
20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 13 💬
331DEXTROMETORFANO HIDROBROMURO1件: Dextromethorphan1件: Dextromethorphan 💬6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬
20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 13 💬
332Dextrometorfano/Quinidina2件: Dextromethorphan,
Quinidine
2件: Dextromethorphan ,
Quinidine 💬
11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬
22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
333Dextrose1件: Dextrose, unspecified form---4件: 60, 65, 70, 226 💬
334Dextrose, 5% in Water2件: Dextrose, unspecified form,
Water
1件: Water 💬--1件: 65 💬
335Dezamizumab1件: Dezamizumab1件: Dezamizumab 💬1件: APCS 💬-1件: 28 💬
336Dezocine1件: Dezocine1件: Dezocine 💬2件: OPRK1,
OPRM1 💬
3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 46 💬
337DF2156A----1件: 162 💬
338DFO----3件: 46, 284, 286 💬
339DFV890----1件: 106 💬
340DGH----1件: 78 💬
341DHA----8件: 6, 46, 48, 49, 94, 113, 299, 301 💬
342DHC----1件: 310 💬
343DHEA1件: Prasterone1件: Prasterone 💬3件: AR,
ESR1,
ESR2 💬
12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬3件: 49, 86, 96 💬
344DHEA tablet1件: Prasterone1件: Prasterone 💬3件: AR,
ESR1,
ESR2 💬
12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 86 💬
345DI-17E6----1件: 51 💬
346DIACEREIN1件: Diacerein1件: Diacerein 💬--3件: 36, 46, 63 💬
347Diacerein 1% Ointment1件: Diacerein1件: Diacerein 💬--1件: 36 💬
348Diacerin cream----1件: 36 💬
349DIACOMIT1件: Stiripentol1件: Stiripentol 💬--1件: 140 💬
350DIACOMIT (Stiripentol)1件: Stiripentol1件: Stiripentol 💬--1件: 140 💬
351Diagnosis of Fabry disease----1件: 19 💬
352Diammonium glycyrrhizinate enteric-coated capsule----1件: 63 💬
353Diazepam1件: Diazepam1件: Diazepam 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬3件: 46, 155, 298 💬
354Diazepam, melatonin2件: Diazepam,
Melatonin
2件: Diazepam ,
Melatonin 💬
18件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
MTNR1A,
MTNR1B 💬
8件: Circadian entrainment, GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 46 💬
355Diazoxide1件: Diazoxide1件: Diazoxide 💬2件: ABCC8,
KCNJ11 💬
4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬2件: 13, 193 💬
356DIAZOXIDE CHOLINE2件: Choline,
Diazoxide
2件: Diazoxide ,
Choline 💬
2件: ABCC8,
KCNJ11 💬
4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 193 💬
357Diazoxide choline controlled-release tablet2件: Choline,
Diazoxide
2件: Diazoxide ,
Choline 💬
2件: ABCC8,
KCNJ11 💬
4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 193 💬
358DIBASE----1件: 13 💬
359DIBASE*IM OS 2F 1ML 300000UI/M----1件: 46 💬
360Dichloroacetate1件: Dichloroacetic acid---1件: 86 💬
361Dichloroacetate Sodium2件: Dichloroacetic acid,
Sodium dichloroacetate
1件: Sodium dichloroacetate 💬3件: PDK2,
PDK3,
PDK4 💬
1件: Diabetic cardiomyopathy 💬1件: 86 💬
362Dichlorphenamide1件: Diclofenamide1件: Dichlorphenamide 💬13件: CA1,
CA12,
CA13,
CA14,
CA2,
CA3,
CA4,
CA5A,
CA5B,
CA6,
CA7,
CA8,
CA9 💬
7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬1件: 114 💬
363Diclofenac1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬5件: 13, 34, 46, 78, 271 💬
364Diclofenac + Omeprazole2件: Diclofenac,
Omeprazole
2件: Omeprazole ,
Diclofenac 💬
4件: ATP4A,
ATP4B,
PTGS1,
PTGS2 💬
26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
365Diclofenac 50 milligrams1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
366Diclofenac Sodium1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 34, 46 💬
367Diclofenac sodium topical gel1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
368Diclofenac SR1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
369Diclophenac----1件: 271 💬
370DICLOXACILLIN1件: Dicloxacillin1件: Dicloxacillin 💬--1件: 299 💬
371Dicynone----1件: 227 💬
372Didanosine1件: Didanosine1件: Didanosine 💬--2件: 25, 265 💬
373Diet----4件: 86, 97, 240, 299 💬
374Diet 1----1件: 96 💬
375Diet 2----1件: 96 💬
376Diet A group----1件: 85 💬
377Diet B group----1件: 85 💬
378Diet C group----1件: 85 💬
379Dietanolamina de treprostinilo1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
380Dietary Fiber Supplementation----1件: 46 💬
381Dietary Supplement for PKU patients----1件: 240 💬
382Dietary supplement omega3 fatty acids aand vitamins----1件: 46 💬
383Dietary therapy----1件: 96 💬
384Diethyl-[6-(4-hydroxycarbamoyl- phenyl carbamoyloxymethyl)-naphthalen-2-yl methyl]-ammonium chloride2件: Ammonium chloride,
Chloride ion
1件: Ammonium chloride 💬--1件: 107 💬
385Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon2件: Ammonium chloride,
Chloride ion
1件: Ammonium chloride 💬--1件: 96 💬
386Diethyldithiocarbamate1件: Ditiocarb---1件: 169 💬
387Dietician designed diet----1件: 96 💬
388Difenidramina----2件: 11, 63 💬
389DIFENIDRAMINA CLORIDRATO----3件: 11, 19, 63 💬
390Different diets----1件: 6 💬
391Different HAART regimens----1件: 265 💬
392Diflucan1件: Fluconazole1件: Fluconazole 💬--1件: 96 💬
393Diflunisal1件: Diflunisal1件: Diflunisal 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 28 💬
394Diflunisal (dolobid)1件: Diflunisal1件: Diflunisal 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 28 💬
395Digitoxin1件: Digitoxin1件: Digitoxin 💬4件: ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4 💬
18件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
396DIGNA P144 CREAM----1件: 51 💬
397Digoxin1件: Digoxin1件: Digoxin 💬4件: ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4 💬
18件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 8, 46, 210 💬
398Digoxin 0.25 mg1件: Digoxin1件: Digoxin 💬4件: ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4 💬
18件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
399Dihuang1件: Rehmannia glutinosa root---3件: 46, 66, 76 💬
400Dihydroartemisinin1件: Artenimol1件: Artenimol 💬--1件: 49 💬
401Dihydroartemisinin tablet1件: Artenimol1件: Artenimol 💬--1件: 49 💬
402Dihydroergotoxine1件: Dihydroergotoxine1件: Dihydroergotoxine 💬--1件: 6 💬
403Dihydroergotoxine Mesylate2件: Dihydroergotoxine,
Ergoloid mesylate
1件: Dihydroergotoxine 💬--1件: 6 💬
404Dihydrogen1件: Hydrogen---1件: 65 💬
405DILATREND----1件: 113 💬
406Diltiazem1件: Diltiazem1件: Diltiazem 💬4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 58, 86 💬
407Diltiazem Gel 2%1件: Diltiazem1件: Diltiazem 💬4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51 💬
408Diltiazem Hydrochloride1件: Diltiazem1件: Diltiazem 💬4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
409Dimebon1件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
410Dimebon (latrepirdine)1件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
411Dimebon + Dextromethorphan2件: Dextromethorphan,
Latrepirdine
2件: Dextromethorphan ,
Latrepirdine 💬
7件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬
22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
412Dimebon + Ketoconazole2件: Ketoconazole,
Latrepirdine
2件: Ketoconazole ,
Latrepirdine 💬
7件: ACHE,
CYP17A1,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
28件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Pathways of neurodegeneration - multiple diseases, Prion disease, Prolactin signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Steroid hormone biosynthesis, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
413Dimebon + Omeprazole2件: Latrepirdine,
Omeprazole
2件: Omeprazole ,
Latrepirdine 💬
8件: ACHE,
ATP4A,
ATP4B,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
26件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
414Dimebon alone1件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
415Dimebon Dihydrochloride1件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
416Dimebon IR1件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
417Dimebon IR Tablet1件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
418Dimebon MR11件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
419Dimebon MR21件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
420Dimebon MR31件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
421Dimebon MR41件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
422Dimebon Transdermal1件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
423DIMENSION1件: Dithiopyr---1件: 55 💬
424DIMETHYL FUMARATE1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬4件: 13, 51, 86, 296 💬
425Dimethyl Fumarate (DMF)1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬3件: 13, 51, 86 💬
426Dimethyl fumarate 240 mg1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
427Dimethyl fumarate [DMF]1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
428Dimethyl sulfoxide1件: Dimethyl sulfoxide1件: Dimethyl sulfoxide 💬--1件: 226 💬
429Dimethyl sulfoxide (DMSO)1件: Dimethyl sulfoxide1件: Dimethyl sulfoxide 💬--1件: 226 💬
430Dimethylfumarat1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 49 💬
431DIMETIL-FUMARATO----1件: 13 💬
432Dimetilfumarato----1件: 13 💬
433Dimeythl Fumarate----1件: 46 💬
434DIMS0150----1件: 97 💬
435Diosmin1件: Diosmin1件: Diosmin 💬--3件: 46, 97, 265 💬
436Diosmin and Hesperidin Combination2件: Diosmin,
Hesperidin
2件: Hesperidin ,
Diosmin 💬
--1件: 46 💬
437Diosminex, 500 mg, tabletki powlekane----1件: 265 💬
438Diovan1件: Valsartan1件: Valsartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58 💬
439Diovan 160 mg1件: Valsartan1件: Valsartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58 💬
440Diovan 40 mg1件: Valsartan1件: Valsartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58 💬
441Diovan 80 mg1件: Valsartan1件: Valsartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58 💬
442Diphenhydramine1件: Diphenhydramine1件: Diphenhydramine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬8件: 11, 13, 49, 51, 70, 86, 222, 256 💬
443Diphenhydramine hydrochloride1件: Diphenhydramine1件: Diphenhydramine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬2件: 11, 49 💬
444Diphenhydramine IV1件: Diphenhydramine1件: Diphenhydramine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
445Diphenydramine----1件: 13 💬
446Diphtheria toxoid1件: Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)---2件: 13, 46 💬
447Dipivefrin1件: Dipivefrin1件: Dipivefrin 💬9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
448Dipivefrine1件: Dipivefrin1件: Dipivefrin 💬9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
449Dipotassium Salt----1件: 46 💬
450Dipraglurant1件: Dipraglurant---1件: 6 💬
451Diprofos Depot----1件: 46 💬
452Dipyridamole1件: Dipyridamole1件: Dipyridamole 💬2件: PDE4A,
PDE5A 💬
6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 46, 49, 51, 66, 96, 224 💬
453Dipyridamole and Amoxapine2件: Amoxapine,
Dipyridamole
2件: Amoxapine ,
Dipyridamole 💬
4件: PDE4A,
PDE5A,
SLC6A2,
SLC6A4 💬
8件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
454Dipyridamole Tab 25 MG1件: Dipyridamole1件: Dipyridamole 💬2件: PDE4A,
PDE5A 💬
6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 224 💬
455Diquafosol1件: Diquafosol---1件: 53 💬
456Diroximel Fumarate1件: Diroximel fumarate1件: Diroximel fumarate 💬--1件: 13 💬
457Diroximel Fumarate (DRF)1件: Diroximel fumarate1件: Diroximel fumarate 💬--1件: 13 💬
458Dirucotide1件: Dirucotide1件: Dirucotide 💬--1件: 13 💬
459Dirucotide acetate2件: Acetate,
Dirucotide
1件: Dirucotide 💬--1件: 13 💬
460DISC-1459----1件: 254 💬
461Discontinuation of disease modifying therapy----1件: 13 💬
462Discontinuation of respiratory co-therapy (azithromycin, RhDNase, or inhaled antibiotics)1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬
--1件: 299 💬
463Disease modified antirheumatic drugs or biological agents----1件: 46 💬
464Disease Modifying therapy----1件: 13 💬
465Disease modifying treatment (DMT)----1件: 13 💬
466Disease modifying treatments----1件: 3 💬
467Disease-modifying anti-rheumatic drugs----1件: 46 💬
468Disease-modifying antirheumatic drug----1件: 46 💬
469Disease-modifying antirheumatic drugs (DMARDs)----1件: 46 💬
470Disodium citrate----1件: 245 💬
471Disodium cromoglycate (DSCG)1件: Cromoglicic acid1件: Cromoglicic acid 💬--1件: 85 💬
472Disodium Cromoglycate [cromolyn sodium]1件: Cromoglicic acid1件: Cromoglicic acid 💬--1件: 85 💬
473Disodium Pamidronate 15mg (15mg strength)1件: Pamidronic acid1件: Pamidronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
474Disodium Pyrophosphate----1件: 166 💬
475Disodiumpyrophosphate----1件: 166 💬
476Ditropan elixir1件: Oxybutynin1件: Oxybutynin 💬5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
477Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhithmias)1件: Amiodarone1件: Amiodarone 💬16件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
KCND3,
KCNJ11,
KCNJ12,
KCNJ3,
KCNJ5,
KCNJ8,
KCNQ1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
32件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 28 💬
478Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus EGCG2件: Amiodarone,
Epigallocatechin gallate
1件: Amiodarone 💬16件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
KCND3,
KCNJ11,
KCNJ12,
KCNJ3,
KCNJ5,
KCNJ8,
KCNQ1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
32件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 28 💬
479DIURF-006----1件: 81 💬
480Divalproex----1件: 8 💬
481Divalproex sodium----1件: 51 💬
482Divozilimab----1件: 13 💬
483Dl-3-n-butylphthalide (NBP)1件: Butylphthalide---1件: 22 💬
484DLX105----1件: 96 💬
485DM----2件: 6, 8 💬
486DM-1992----1件: 6 💬
487DMARD----1件: 46 💬
488DMARD cessation----1件: 46 💬
489DMARD maintenance----1件: 46 💬
490DMARD Therapy----1件: 46 💬
491DMARDS----2件: 46, 271 💬
492DMARDs (disease-modifying antirheumatic drugs)----1件: 46 💬
493DMARDs (methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬
5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
494DMARDs or Biologics----1件: 46 💬
495DMPS1件: 2,3-Dimercapto-1-propanesulfonic acid---1件: 171 💬
496DMSA1件: Succimer1件: Succimer 💬--1件: 171 💬
497DMSO1件: Dimethyl sulfoxide1件: Dimethyl sulfoxide 💬--1件: 226 💬
498DMSO cocktail1件: Dimethyl sulfoxide1件: Dimethyl sulfoxide 💬--1件: 226 💬
499DMT----1件: 13 💬
500DMT continuation----1件: 13 💬
501DMX-200----1件: 222 💬
502DNA analysis----1件: 60 💬
503DNA/GeneticTesting----1件: 6 💬
504DnaJ peptide----1件: 46 💬
505DNL151----1件: 6 💬
506DNL151, DN0001575, DN1575----1件: 6 💬
507DNL201----1件: 6 💬
508DNL310----1件: 19 💬
509DNL310 Drug Substance----1件: 19 💬
510DNL343----1件: 2 💬
511DNL593----1件: 127 💬
512DNL593 Sterile Lyophilisate----1件: 127 💬
513DNL747----1件: 2 💬
514DNS-7801 (high dose)----1件: 6 💬
515DNS-7801 (low-dose)----1件: 6 💬
516Dobutamin1件: Dobutamine1件: Dobutamine 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 215 💬
517Dobutamine1件: Dobutamine1件: Dobutamine 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 57, 58, 86, 215 💬
518Dobutamine test1件: Dobutamine1件: Dobutamine 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
519Docosahexaenoic acid1件: Doconexent---7件: 6, 49, 90, 94, 240, 299, 301 💬
520Docosahexaenoic Acid (DHA)1件: Doconexent---3件: 6, 94, 299 💬
521Docosahexaenoic Acid (DHA) Dietary Supplement1件: Doconexent---1件: 301 💬
522Docosahexaenoic acid administration: 50 mg/kg/day during 12 months1件: Doconexent---1件: 299 💬
523Docosahexanoic Acid1件: Doconexent---1件: 299 💬
524Docosahexanoic Acid Supplement1件: Doconexent---1件: 299 💬
525Dolasetron1件: Dolasetron1件: Dolasetron 💬5件: HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬
2件: Serotonergic synapse, Taste transduction 💬1件: 46 💬
526Dolobid----1件: 28 💬
527Dolquine----1件: 46 💬
528Dolutegravir1件: Dolutegravir1件: Dolutegravir 💬--2件: 2, 265 💬
529Dolutegravir / Lamivudine Oral Tablet2件: Dolutegravir,
Lamivudine
2件: Lamivudine ,
Dolutegravir 💬
--1件: 265 💬
530Dolutegravir 50 MG1件: Dolutegravir1件: Dolutegravir 💬--1件: 265 💬
531Dolutegravir, Abacavir and Lamivudine3件: Abacavir,
Dolutegravir,
Lamivudine
3件: Lamivudine ,
Abacavir ,
Dolutegravir 💬
--1件: 2 💬
532Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO]2件: Dolutegravir,
Lamivudine
2件: Lamivudine ,
Dolutegravir 💬
--1件: 265 💬
533Domperidone1件: Domperidone2件: Domperidone ,
Domperidone maleate 💬
1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬5件: 6, 13, 17, 51, 230 💬
534Domperidone (drug)1件: Domperidone2件: Domperidone ,
Domperidone maleate 💬
1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
535Dompéridone----1件: 6 💬
536Donepezil1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬9件: 5, 6, 13, 46, 78, 124, 127, 156, 206 💬
537Donepezil HCI (drug)1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13 💬
538Donepezil Hydrochloride1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬3件: 6, 124, 156 💬
539Donepezil Sandoz1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
540Donor Lymphocyte Infusion (DLI)----1件: 60 💬
541Donor lymphocytes----1件: 28 💬
542Donor mesenchymal stem cell infusions----1件: 36 💬
543Donor peripheral blood stem cells.----1件: 65 💬
544DopaFuse Delivery System----1件: 6 💬
545Dopamina1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 299 💬
546Dopamine1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 7, 74 💬
547Dopamine Agent1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
548Dopamine agonist treatment1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 74 💬
549Dopamine Agonists1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 74 💬
550Dopamine Agonists (pramipexole, ropirinole)2件: Dopamine,
Pramipexole
2件: Pramipexole ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
551Dopaminergic Agonist + Apomorphine1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
552Dopaminergic Agonists----1件: 6 💬
553DOPS1件: Droxidopa1件: Droxidopa 💬9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 6, 17 💬
554Doptelet1件: Avatrombopag1件: Avatrombopag 💬1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63 💬
555Doptelet 20 mg film-coated tablets1件: Avatrombopag1件: Avatrombopag 💬1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63 💬
556Doravirine1件: Doravirine1件: Doravirine 💬--1件: 265 💬
557Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]4件: Doravirine,
Lamivudine,
Tenofovir,
Tenofovir disoproxil
3件: Lamivudine ,
Tenofovir ,
Doravirine 💬
--1件: 265 💬
558DORIBAX1件: Doripenem1件: Doripenem 💬--1件: 299 💬
559Doripenem1件: Doripenem1件: Doripenem 💬--1件: 299 💬
560DORIPENEM HYDRATE1件: Doripenem1件: Doripenem 💬--1件: 299 💬
561Dornase alfa1件: Dornase alfa1件: Dornase alfa 💬--2件: 53, 299 💬
562Dornase alfa (Pulmozyme)1件: Dornase alfa1件: Dornase alfa 💬--1件: 299 💬
563Dornase alfa [Pulmozyme®]1件: Dornase alfa1件: Dornase alfa 💬--1件: 299 💬
564Dornase alpha1件: Dornase alfa1件: Dornase alfa 💬--1件: 299 💬
565Dorzolamide1件: Dorzolamide1件: Dorzolamide 💬13件: CA1,
CA12,
CA13,
CA14,
CA2,
CA3,
CA4,
CA5A,
CA5B,
CA6,
CA7,
CA8,
CA9 💬
7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬1件: 90 💬
566Dosage of cytokines----1件: 50 💬
567Dose level 1----1件: 46 💬
568Dose level 2----1件: 46 💬
569Dose level 3----1件: 46 💬
570Dose level 4----1件: 46 💬
571Dose of 60 mg/kg alpha1-proteinase inhibitor1件: Alpha-1-proteinase inhibitor---1件: 231 💬
572Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor1件: Alpha-1-proteinase inhibitor---1件: 231 💬
573Dose-Establishing Study 1 Niacin 250mg1件: Niacin1件: Niacin 💬--1件: 78 💬
574Dose-Establishing Study 1 Niacin 500mg1件: Niacin1件: Niacin 💬--1件: 78 💬
575Dose-Establishing Study 2 Niacin 500mg1件: Niacin1件: Niacin 💬--1件: 78 💬
576Dosing Extension----1件: 113 💬
577Dosing Interruption of Natalizumab1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
578DOSTINEX1件: Cabergoline1件: Cabergoline 💬2件: DRD2,
PRL 💬
12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 75 💬
579DOTANOC----1件: 84 💬
580Dotarem1件: Gadoteric acid1件: Gadoteric acid 💬--1件: 13 💬
581Dotarem 0,5mmol/ml,1件: Gadoteric acid1件: Gadoteric acid 💬--1件: 13 💬
582Dotatate1件: Dotatate---1件: 84 💬
583Double Dose----2件: 38, 162 💬
584Double-blind Abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬
13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
585Double-blind adalimumab1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 107 💬
586Double-Blind Rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 51 💬
587Doxazosin1件: Doxazosin1件: Doxazosin 💬3件: ADRA1A,
ADRA1B,
ADRA1D 💬
7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 57, 67 💬
588Doxepin1件: Doxepin1件: Doxepin 💬3件: HRH1,
SLC6A2,
SLC6A4 💬
5件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
589Doxepin and Zopiclone2件: Doxepin,
Zopiclone
2件: Zopiclone ,
Doxepin 💬
19件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
HRH1,
SLC6A2,
SLC6A4 💬
10件: Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction 💬1件: 6 💬
590Doxil----1件: 63 💬
591Doxorubicin1件: Doxorubicin1件: Doxorubicin 💬2件: TOP2A,
TOP2B 💬
1件: Platinum drug resistance 💬5件: 26, 28, 34, 65, 331 💬
592Doxorubicin Hydrochloride1件: Doxorubicin1件: Doxorubicin 💬2件: TOP2A,
TOP2B 💬
1件: Platinum drug resistance 💬3件: 26, 34, 331 💬
593Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase4件: Asparaginase Escherichia coli,
Cyclophosphamide,
Doxorubicin,
Methotrexate
4件: Methotrexate ,
Cyclophosphamide ,
Doxorubicin ,
Cyclophosphamide 💬
4件: DHFR,
DHFR2,
TOP2A,
TOP2B 💬
6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Platinum drug resistance 💬1件: 65 💬
594Doxy----1件: 34 💬
595Doxycyclin1件: Doxycycline2件: Doxycycline ,
Doxycycline 💬
--2件: 97, 299 💬
596Doxycycline1件: Doxycycline2件: Doxycycline ,
Doxycycline 💬
--17件: 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 💬
597Doxycycline 100 mg Capsules1件: Doxycycline2件: